Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review

•Chemotherapy-induced neutropenia can lead to poor clinical outcomes.•CIN can lead to infections, hospitalizations, mortality, and lower chemotherapy dose intensity.•G-CSF agents have been the standard of care for the prevention of CIN for 30 years.•Emerging therapies will likely change the standard approach for CIN prevention.